<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39449862</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7007</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Diabetes, metabolic syndrome and obesity : targets and therapy</Title><ISOAbbreviation>Diabetes Metab Syndr Obes</ISOAbbreviation></Journal><ArticleTitle>Type 2 Diabetes Mellitus Aggravates Complement Dysregulation and Affects Cortisol Response in Patients with Post-COVID-19.</ArticleTitle><Pagination><StartPage>3849</StartPage><EndPage>3861</EndPage><MedlinePgn>3849-3861</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/DMSO.S480457</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">COVID-19 viral infection results in dysregulation of the complement system and a decrease in cortisol and adrenocorticotropin hormone (ACTH) levels. This study aimed to explore the complement system, as well as cortisol and ACTH responses in patients with post-COVID-19 conditions (PCC) and type 2 diabetes mellitus (T2DM).</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">This study recruited 31 patients with PCC and T2DM (PCC-T2DM), 19 patients with PCC (PCC), 10 patients with T2DM (T2DM), and 10 healthy participants (control). Cortisol and ACTH in the PCC and PCC-T2DM groups were assessed using the insulin tolerance test. In the fasting state, serum samples were collected for proteomic analyses. Spearman correlation analysis was performed between proteins and cortisol, as well as between proteins and ACTH.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Cortisol and ACTH levels were consistently decreased in the PCC and PCC-T2DM groups. Proteomic analyses revealed that most of the differentially abundant proteins (DAPs) in the PCC vs control and PCC-T2DM vs T2DM were involved in the coagulation and complement cascade, and the essential complement C3 was significantly upregulated in the PCC and PCC-T2DM groups when compared to their controls. Additionally, complement-related DAPs in the PCC vs control and PCC-T2DM vs T2DM were significantly correlated with cortisol and ACTH levels. In comparing PCC-T2DM samples with PCC samples, we found that upregulated DAPs were linked to the complement system and other immune system, and most DAPs were negatively correlated with cortisol and ACTH.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our study revealed that T2DM exacerbated dysregulation of the complement system in patients with PCC, and significant correlations were present between complement protein levels and those of cortisol and ACTH. These results provide novel insights into the dysregulation of complement and endocrine hormones in patients with PCC and T2DM.</AbstractText><CopyrightInformation>© 2024 Ji et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ji</LastName><ForeName>Wenrui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, the First People's Hospital of Yinchuan, Yinchuan, 750001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xie</LastName><ForeName>Xiaomin</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-6030-7915</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, the First People's Hospital of Yinchuan, Yinchuan, 750001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Guirong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, the First People's Hospital of Yinchuan, Yinchuan, 750001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Yalei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Second Clinical Medical School of Ningxia Medical University, Yinchuan, 750001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yanting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, the First People's Hospital of Yinchuan, Yinchuan, 750001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, the First People's Hospital of Yinchuan, Yinchuan, 750001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Haiyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, the First People's Hospital of Yinchuan, Yinchuan, 750001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, the First People's Hospital of Yinchuan, Yinchuan, 750001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiang</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, the First People's Hospital of Yinchuan, Yinchuan, 750001, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Huan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, the First People's Hospital of Yinchuan, Yinchuan, 750001, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Diabetes Metab Syndr Obes</MedlineTA><NlmUniqueID>101515585</NlmUniqueID><ISSNLinking>1178-7007</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adrenocorticotropin hormone</Keyword><Keyword MajorTopicYN="N">complement</Keyword><Keyword MajorTopicYN="N">cortisol</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">type 2 diabetes mellitus</Keyword></KeywordList><CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>4</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39449862</ArticleId><ArticleId IdType="pmc">PMC11499617</ArticleId><ArticleId IdType="doi">10.2147/DMSO.S480457</ArticleId><ArticleId IdType="pii">480457</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sukocheva OA, Maksoud R, Beeraka NM. et al. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J Adv Res. 2022;40:179–196. doi:10.1016/j.jare.2021.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102–e07. doi:10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox JR, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623(7985):139–148. doi:10.1038/s41586-023-06651-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte C, Cipponeri E, Roden M. Diabetes mellitus, energy metabolism, and COVID-19. Endocr Rev. 2024;45(2):281–308 doi:10.1210/endrev/bnad032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endrev/bnad032</ArticleId><ArticleId IdType="pmc">PMC10911957</ArticleId><ArticleId IdType="pubmed">37934800</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassar M, Daoud A, Nso N, et al. Diabetes mellitus and COVID-19: review Article. Diabetes Metab Syndr. 2021;15(6):102268. doi:10.1016/j.dsx.2021.102268</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102268</ArticleId><ArticleId IdType="pmc">PMC8416292</ArticleId><ArticleId IdType="pubmed">34562865</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima-Martinez MM, Carrera Boada C, Madera-Silva MD, Marin W, Contreras M. COVID-19 and diabetes: a bidirectional relationship. Clin Investig Arterioscler. 2021;33(3):151–157. doi:10.1016/j.arteri.2020.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arteri.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7598432</ArticleId><ArticleId IdType="pubmed">33303218</ArticleId></ArticleIdList></Reference><Reference><Citation>Somasundaram NP, Ranathunga I, Ratnasamy V, et al. The impact of SARS-Cov-2 virus infection on the endocrine system. J Endocr Soc. 2020;4(8):bvaa082. doi:10.1210/jendso/bvaa082</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvaa082</ArticleId><ArticleId IdType="pmc">PMC7337839</ArticleId><ArticleId IdType="pubmed">32728654</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceriello A. Hyperglycemia and COVID-19: what was known and what is really new? Diabet Res Clin Pract. 2020;167:108383. doi:10.1016/j.diabres.2020.108383</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108383</ArticleId><ArticleId IdType="pmc">PMC7445137</ArticleId><ArticleId IdType="pubmed">32853690</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133–146. doi:10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737–754. doi:10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiya H, Tokumasu K, Otsuka Y, et al. Relevance of complement immunity with brain fog in patients with long COVID. J Infect Chemother. 2024;30(3):236–241. doi:10.1016/j.jiac.2023.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2023.10.016</ArticleId><ArticleId IdType="pubmed">37866620</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia-Hasler C, Bruningk SC, Hoch T, et al. Persistent complement dysregulation with signs of thromboinflammation in active long covid. Science. 2024;383(6680):eadg7942. doi:10.1126/science.adg7942</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adg7942</ArticleId><ArticleId IdType="pubmed">38236961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Sahu SK, Cano M, et al. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. Sci Immunol. 2021;6(59). doi:10.1126/sciimmunol.abh2259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abh2259</ArticleId><ArticleId IdType="pmc">PMC8158979</ArticleId><ArticleId IdType="pubmed">34446527</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajjan RA, Schroeder V. Role of complement in diabetes. Mol Immunol. 2019;114:270–277. doi:10.1016/j.molimm.2019.07.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2019.07.031</ArticleId><ArticleId IdType="pubmed">31400630</ArticleId></ArticleIdList></Reference><Reference><Citation>Flyvbjerg A. The role of the complement system in diabetic nephropathy. Nat Rev Nephrol. 2017;13(5):311–318. doi:10.1038/nrneph.2017.31</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.31</ArticleId><ArticleId IdType="pubmed">28262777</ArticleId></ArticleIdList></Reference><Reference><Citation>King BC, Blom AM. Non-traditional roles of complement in type 2 diabetes: metabolism, insulin secretion and homeostasis. Mol Immunol. 2017;84:34–42. doi:10.1016/j.molimm.2016.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2016.12.009</ArticleId><ArticleId IdType="pubmed">28012560</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R. COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Endocrine. 2020;68(2):251–252. doi:10.1007/s12020-020-02325-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02325-1</ArticleId><ArticleId IdType="pmc">PMC7186765</ArticleId><ArticleId IdType="pubmed">32346813</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581(7807):215–220. doi:10.1038/s41586-020-2180-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2180-5</ArticleId><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Oguz SH, Yildiz BO. Endocrine Disorders and COVID-19. Annu Rev Med. 2023;74(1):75–88. doi:10.1146/annurev-med-043021-033509</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-043021-033509</ArticleId><ArticleId IdType="pubmed">36151047</ArticleId></ArticleIdList></Reference><Reference><Citation>MS C, Ramesh J. Evaluation of the hypothalamo-pituitary-adrenal axis during the post-COVID-19 period in patients treated with steroids during the illness. Arch Endocrinol Metab. 2023;68:e220207. doi:10.20945/2359-4292-2022-0207</Citation><ArticleIdList><ArticleId IdType="doi">10.20945/2359-4292-2022-0207</ArticleId><ArticleId IdType="pmc">PMC10916833</ArticleId><ArticleId IdType="pubmed">37948563</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzahrani AS, Mukhtar N, Aljomaiah A, et al. The Impact of COVID-19 viral infection on the hypothalamic-pituitary-adrenal axis. Endocr Pract. 2021;27(2):83–89. doi:10.1016/j.eprac.2020.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2020.10.014</ArticleId><ArticleId IdType="pmc">PMC7837186</ArticleId><ArticleId IdType="pubmed">33554871</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi I, Estabraghnia Babaki H, Maleki M, et al. Changes in physiological levels of cortisol and adrenocorticotropic hormone upon hospitalization can predict SARS-CoV-2 mortality: a cohort study. Int J Endocrinol. 2022;2022:4280691. doi:10.1155/2022/4280691</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/4280691</ArticleId><ArticleId IdType="pmc">PMC8896943</ArticleId><ArticleId IdType="pubmed">35251166</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeager MP, Guyre CA, Sites BD, et al. The stress hormone cortisol enhances interferon-upsilon-mediated proinflammatory responses of human immune cells. Anesth Analg. 2018;127(2):556–563. doi:10.1213/ANE.0000000000003481</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000003481</ArticleId><ArticleId IdType="pubmed">30028389</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung WK, Erion K, Florez JC, et al. Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2020;43(7):1617–1635. doi:10.2337/dci20-0022</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dci20-0022</ArticleId><ArticleId IdType="pmc">PMC7305007</ArticleId><ArticleId IdType="pubmed">32561617</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji W, Xie X, Bai G, et al. Metabolomic approaches to dissect dysregulated metabolism in the progression of pre-diabetes to T2DM. Mol Omics. 2024;20(5):333–347. doi:10.1039/D3MO00130J</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D3MO00130J</ArticleId><ArticleId IdType="pubmed">38686662</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond JB, Soares BS, Vieira ELM, et al. Interleukin-6 response to insulin-induced hypoglycemia is associated with hypothalamic-pituitary-adrenal axis activation. J Neuroimmunol. 2020;350:577446. doi:10.1016/j.jneuroim.2020.577446</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2020.577446</ArticleId><ArticleId IdType="pubmed">33227660</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedmann AP, Koutychenko A, Wu C, et al. Identification and characterization of a factor Va-binding site on human prothrombin fragment 2. Sci Rep. 2019;9(1):2436. doi:10.1038/s41598-019-38857-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-38857-4</ArticleId><ArticleId IdType="pmc">PMC6385242</ArticleId><ArticleId IdType="pubmed">30792421</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber-Lang M, Sarma JV, Zetoune FS, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med. 2006;12(6):682–687. doi:10.1038/nm1419</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1419</ArticleId><ArticleId IdType="pubmed">16715088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Wu YQ, Ricklin D, et al. Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat Immunol. 2009;10(7):728–733. doi:10.1038/ni.1755</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1755</ArticleId><ArticleId IdType="pmc">PMC2713992</ArticleId><ArticleId IdType="pubmed">19503104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy AT, Schmidt CQ, Thompson JK, et al. Recruitment of factor h as a novel complement evasion strategy for blood-stage plasmodium falciparum infection. J Immunol. 2016;196(3):1239–1248. doi:10.4049/jimmunol.1501581</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501581</ArticleId><ArticleId IdType="pubmed">26700768</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalska D, Kuzniewska A, Senent Y, et al. C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d. Front Immunol. 2022;13:946522. doi:10.3389/fimmu.2022.946522</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.946522</ArticleId><ArticleId IdType="pmc">PMC9448977</ArticleId><ArticleId IdType="pubmed">36091057</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarlhelt I, Nielsen SK, Jahn CXH, et al. SARS-CoV-2 antibodies mediate complement and cellular driven inflammation. Front Immunol. 2021;12:767981. doi:10.3389/fimmu.2021.767981</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.767981</ArticleId><ArticleId IdType="pmc">PMC8596567</ArticleId><ArticleId IdType="pubmed">34804055</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallis R, Mitchell DA, Schmid R, Schwaeble WJ, Keeble AH. Paths reunited: initiation of the classical and lectin pathways of complement activation. Immunobiology. 2010;215(1):1–11. doi:10.1016/j.imbio.2009.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2009.08.006</ArticleId><ArticleId IdType="pmc">PMC2824237</ArticleId><ArticleId IdType="pubmed">19783065</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaboriaud C, Thielens NM, Gregory LA, et al. Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol. 2004;25(7):368–373. doi:10.1016/j.it.2004.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2004.04.008</ArticleId><ArticleId IdType="pubmed">15207504</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobo J, Pal G, Cervenak L, Gal P. The emerging roles of mannose-binding lectin-associated serine proteases (MASPs) in the lectin pathway of complement and beyond. Immunol Rev. 2016;274(1):98–111. doi:10.1111/imr.12460</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12460</ArticleId><ArticleId IdType="pubmed">27782318</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathern DR, Heeger PS. Molecules Great and Small: the Complement System. Clin J Am Soc Nephrol. 2015;10(9):1636–1650. doi:10.2215/CJN.06230614</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.06230614</ArticleId><ArticleId IdType="pmc">PMC4559511</ArticleId><ArticleId IdType="pubmed">25568220</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarantonello A, Revel M, Grunenwald A, Roumenina LT. C3-dependent effector functions of complement. Immunol Rev. 2023;313(1):120–138. doi:10.1111/imr.13147</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.13147</ArticleId><ArticleId IdType="pmc">PMC10092904</ArticleId><ArticleId IdType="pubmed">36271889</ArticleId></ArticleIdList></Reference><Reference><Citation>Skendros P, Germanidis G, Mastellos DC, et al. Complement C3 inhibition in severe COVID-19 using compstatin AMY-101. Sci Adv. 2022;8(33):eabo2341. doi:10.1126/sciadv.abo2341</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abo2341</ArticleId><ArticleId IdType="pmc">PMC9385148</ArticleId><ArticleId IdType="pubmed">35977025</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang S, Wang H, Lu L, Jia Y, Xia Z. Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: a retrospective cohort study. Int Immunopharmacol. 2020;89(Pt A):107070. doi:10.1016/j.intimp.2020.107070</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107070</ArticleId><ArticleId IdType="pmc">PMC7534659</ArticleId><ArticleId IdType="pubmed">33039965</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Chen Q, Zheng S, et al. Association of Complement C3 with clinical deterioration among hospitalized patients with COVID-19. Int J Gen Med. 2022;15:849–857. doi:10.2147/IJGM.S348519</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S348519</ArticleId><ArticleId IdType="pmc">PMC8801723</ArticleId><ArticleId IdType="pubmed">35115811</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremlitzka M, Macsik-Valent B, Erdei A. Regulation of B cell functions by Toll-like receptors and complement. Immunol Lett. 2016;178:37–44. doi:10.1016/j.imlet.2016.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2016.07.015</ArticleId><ArticleId IdType="pubmed">27485187</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin AV, Cardenas PP, Jimenez-Reinoso A, Munoz-Ruiz M, Regueiro JR. Lymphocyte integration of complement cues. Semin Cell Dev Biol. 2019;85:132–142. doi:10.1016/j.semcdb.2018.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2018.02.005</ArticleId><ArticleId IdType="pubmed">29438807</ArticleId></ArticleIdList></Reference><Reference><Citation>West EE, Kolev M, Kemper C. Complement and the regulation of T cell responses. Annu Rev Immunol. 2018;36(1):309–338. doi:10.1146/annurev-immunol-042617-053245</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042617-053245</ArticleId><ArticleId IdType="pmc">PMC7478175</ArticleId><ArticleId IdType="pubmed">29677470</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamazaki K, Nishigaki T, Kuramoto N, Oh K, Konishi H. Secondary adrenal insufficiency after COVID-19 diagnosed by insulin tolerance test and corticotropin-releasing hormone test. Cureus. 2022;14(3):e23021 doi:10.7759/cureus.23021.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.23021</ArticleId><ArticleId IdType="pmc">PMC8908067</ArticleId><ArticleId IdType="pubmed">35281581</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller WL. The hypothalamic-pituitary-adrenal axis: a brief history. Horm Res Paediatr. 2018;89(4):212–223. doi:10.1159/000487755</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000487755</ArticleId><ArticleId IdType="pubmed">29719288</ArticleId></ArticleIdList></Reference><Reference><Citation>Freire Santana M, Borba MGS, Baia-da-silva DC, et al. Case report: adrenal pathology findings in severe COVID-19: an autopsy study. Am J Trop Med Hyg. 2020;103(4):1604–1607. doi:10.4269/ajtmh.20-0787</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0787</ArticleId><ArticleId IdType="pmc">PMC7543860</ArticleId><ArticleId IdType="pubmed">32876012</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyendecker P, Ritter S, Riou M, et al. Acute adrenal infarction as an incidental CT finding and a potential prognosis factor in severe SARS-CoV-2 infection: a retrospective cohort analysis on 219 patients. Eur Radiol. 2021;31(2):895–900. doi:10.1007/s00330-020-07226-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-020-07226-5</ArticleId><ArticleId IdType="pmc">PMC7450155</ArticleId><ArticleId IdType="pubmed">32852586</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya MG, Alanli R, Kucukay MB, Ulukaya FB, Bakir F. Pituitary functions after recovery from covid-19. Acta Endocrinol. 2023;19(3):314–318. doi:10.4183/aeb.2023.314</Citation><ArticleIdList><ArticleId IdType="doi">10.4183/aeb.2023.314</ArticleId><ArticleId IdType="pmc">PMC10863953</ArticleId><ArticleId IdType="pubmed">38356979</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavropoulou MP, Tsokos GC, Chrousos GP, Sfikakis PP. Protracted stress-induced hypocortisolemia may account for the clinical and immune manifestations of Long COVID. Clin Immunol. 2022;245:109133. doi:10.1016/j.clim.2022.109133</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2022.109133</ArticleId><ArticleId IdType="pmc">PMC9519365</ArticleId><ArticleId IdType="pubmed">36182048</ArticleId></ArticleIdList></Reference><Reference><Citation>Isidori AM, Minnetti M, Sbardella E, Graziadio C, Grossman AB. Mechanisms in endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect. Eur J Endocrinol. 2015;173(3):R101–13. doi:10.1530/EJE-15-0308</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-15-0308</ArticleId><ArticleId IdType="pubmed">25987566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante E, Serban AL, Clerici M, et al. Evaluation of procoagulant imbalance in Cushing’s syndrome after short- and long-term remission of disease. J Endocrinol Invest. 2022;45(1):9–16. doi:10.1007/s40618-021-01605-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01605-5</ArticleId><ArticleId IdType="pmc">PMC8741706</ArticleId><ArticleId IdType="pubmed">34115342</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiatkowska-Stodulska R, Mital A, Wisniewski P, et al. Assessment of platelet function in endogenous hypercortisolism. Endokrynol Pol. 2015;66(3):207–213. doi:10.5603/EP.2015.0014</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/EP.2015.0014</ArticleId><ArticleId IdType="pubmed">26136128</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischli S, von Wyl V, Wuillemin W, et al. Impact of adrenal function on hemostasis/endothelial function in patients undergoing surgery. J Endocr Soc. 2021;5(5):bvab047. doi:10.1210/jendso/bvab047</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvab047</ArticleId><ArticleId IdType="pmc">PMC8057135</ArticleId><ArticleId IdType="pubmed">33928206</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastelan D, Dusek T, Kraljevic I, et al. Hypercoagulability in Cushing’s syndrome: the role of specific haemostatic and fibrinolytic markers. Endocrine. 2009;36(1):70–74. doi:10.1007/s12020-009-9186-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-009-9186-y</ArticleId><ArticleId IdType="pubmed">19381886</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Rojas RM, Perez-Rus G, Delgado-Pinos VE, et al. COVID-19 coagulopathy: an in-depth analysis of the coagulation system. Eur J Haematol. 2020;105(6):741–750. doi:10.1111/ejh.13501</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejh.13501</ArticleId><ArticleId IdType="pmc">PMC7436538</ArticleId><ArticleId IdType="pubmed">32749010</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Ni Cheallaigh C, et al. COVID19 coagulopathy in caucasian patients. Br J Haematol. 2020;189(6):1044–1049. doi:10.1111/bjh.16749</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16749</ArticleId><ArticleId IdType="pmc">PMC7264579</ArticleId><ArticleId IdType="pubmed">32330308</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang K, Holt M, Fan M, et al. Cardiovascular Dysfunction in COVID-19: association Between Endothelial Cell Injury and Lactate. Front Immunol. 2022;13:868679. doi:10.3389/fimmu.2022.868679</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.868679</ArticleId><ArticleId IdType="pmc">PMC8984030</ArticleId><ArticleId IdType="pubmed">35401579</ArticleId></ArticleIdList></Reference><Reference><Citation>Valencia I, Lumpuy-Castillo J, Magalhaes G, et al. Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus. Cardiovasc Diabetol. 2024;23(1):75. doi:10.1186/s12933-023-02097-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-023-02097-8</ArticleId><ArticleId IdType="pmc">PMC10880237</ArticleId><ArticleId IdType="pubmed">38378550</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Lang J, Jin L, et al. Effect of hirsutella sinensis fungus on the hypothalamic-pituitary-adrenal axis in lewis rats with kidney-yang deficiency syndrome. Evid Based Complement Alternat Med. 2020;2020(1):5952612. doi:10.1155/2020/5952612</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5952612</ArticleId><ArticleId IdType="pmc">PMC7256706</ArticleId><ArticleId IdType="pubmed">32565866</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis K, Lewis BM, Monk PN, Ham J. Complement C5a receptors in the pituitary gland: expression and function. J Endocrinol. 2008;199(3):417–424. doi:10.1677/JOE-08-0110</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/JOE-08-0110</ArticleId><ArticleId IdType="pubmed">19020281</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis K, Lewis BM, Akatsu H, et al. Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation. FASEB J. 2003;17(15):2266–2268. doi:10.1096/fj.02-1103fje</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.02-1103fje</ArticleId><ArticleId IdType="pubmed">14563692</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C, D’Onofrio N, Balestrieri ML, et al. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? Diabetes Care. 2020;43(7):1408–1415. doi:10.2337/dc20-0723</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0723</ArticleId><ArticleId IdType="pmc">PMC7305003</ArticleId><ArticleId IdType="pubmed">32430456</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Li M, Dong Y, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36(7):e3319. doi:10.1002/dmrr.3319</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3319</ArticleId><ArticleId IdType="pmc">PMC7228407</ArticleId><ArticleId IdType="pubmed">32233013</ArticleId></ArticleIdList></Reference><Reference><Citation>Nougier C, Benoit R, Simon M, et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J Thromb Haemost. 2020;18(9):2215–2219. doi:10.1111/jth.15016</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15016</ArticleId><ArticleId IdType="pmc">PMC7405476</ArticleId><ArticleId IdType="pubmed">32668058</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Weber NC, Cohn DM, et al. Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis. J Clin Med. 2021;10(11):2419. doi:10.3390/jcm10112419</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112419</ArticleId><ArticleId IdType="pmc">PMC8199251</ArticleId><ArticleId IdType="pubmed">34072487</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz Ocaranza M, Riquelme JA, Garcia L, et al. Counter-regulatory renin-angiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020;17(2):116–129. doi:10.1038/s41569-019-0244-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-019-0244-8</ArticleId><ArticleId IdType="pmc">PMC7097090</ArticleId><ArticleId IdType="pubmed">31427727</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanza K, Perez LG, Costa LB, et al. Covid-19: the renin-angiotensin system imbalance hypothesis. Clin Sci (Lond). 2020;134(11):1259–1264. doi:10.1042/CS20200492</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200492</ArticleId><ArticleId IdType="pmc">PMC7276636</ArticleId><ArticleId IdType="pubmed">32507883</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>